KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 87 filers reported holding KARUNA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,182,143 | -12.2% | 545,073 | +12.6% | 0.01% | -8.3% |
Q2 2023 | $104,987,347 | -4.1% | 484,147 | -19.6% | 0.01% | -14.3% |
Q1 2023 | $109,426,357 | +103701.4% | 602,435 | +12.3% | 0.01% | -6.7% |
Q4 2022 | $105,419 | -99.9% | 536,487 | +6.1% | 0.02% | -11.8% |
Q3 2022 | $113,781,000 | +111.9% | 505,851 | +19.2% | 0.02% | +112.5% |
Q2 2022 | $53,690,000 | +6.4% | 424,400 | +6.7% | 0.01% | +33.3% |
Q1 2022 | $50,446,000 | -0.7% | 397,875 | +2.6% | 0.01% | 0.0% |
Q4 2021 | $50,812,000 | +12.8% | 387,878 | +5.3% | 0.01% | 0.0% |
Q3 2021 | $45,060,000 | +10.1% | 368,355 | +2.6% | 0.01% | 0.0% |
Q2 2021 | $40,919,000 | +15.5% | 358,971 | +21.8% | 0.01% | +20.0% |
Q1 2021 | $35,436,000 | +36.4% | 294,738 | +15.2% | 0.01% | +25.0% |
Q4 2020 | $25,986,000 | +35.1% | 255,797 | +2.9% | 0.00% | 0.0% |
Q3 2020 | $19,229,000 | -16.0% | 248,706 | +21.2% | 0.00% | -20.0% |
Q2 2020 | $22,880,000 | +86.7% | 205,283 | +20.6% | 0.01% | +66.7% |
Q1 2020 | $12,255,000 | -8.4% | 170,220 | -4.2% | 0.00% | +200.0% |
Q4 2019 | $13,380,000 | +1075.7% | 177,604 | +154.6% | 0.00% | – |
Q3 2019 | $1,138,000 | – | 69,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |